North American Pharmaceutical & Biotech Industry Outlook Forecasts $16.3 Billion in 2010 Project Starts

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Industrial Info Resources is pleased to announce the release of the 2010 Pharmaceutical & Biotech Industry Outlook. With the entire industry--if not the world--in a state of transition, the importance of having a tool that provides understanding and knowledge has never been more essential. Tap into the pulse of the North American Pharmaceutical & Biotech Industry, using a clear, concise format that demystifies this lucrative and constantly evolving industry.

The 2010 North American Pharmaceutical & Biotech Industry forecast for capital expenditures is estimated to be $18.35 billion, up from $17.25 billion in 2009. Each year, Industrial Info Resources provides an overall spending forecast, with the numbers representing total expenditures for capital and maintenance as they relate to the North American Pharmaceutical & Biotech Industry. The forecast is derived by applying a confidence factor based on historical spending trends to the baseline project activity that Industrial Info is currently tracking. We then use actual projects identified from our research to analyze the trends, as they relate to geography, project type and budget type. As of February 1, 2010, the actual reported count for projects scheduled to begin construction during 2010 in North America is 527, representing a total investment value of $16.3 billion. These projects are measured on the scheduled kick-off date and are valued at $1 million and greater, and can be viewed as the largest portion of the total expenditure of $18.35 billion.

When using the 2010 Pharmaceutical & Biotech Industry Outlook, there is no need for the endless searching that often nets too much information that overwhelms rather than informs. Industrial Info has done the homework for you and packaged useful, timely and essential information and statistics into one easy-to-use format. Features include upcoming trends, vital plant and project statistics, as well as a capital and maintenance spending analysis derived from our information databases.

Setting the outlook apart from any aspiring competitors is that, in addition to having access to its clearly written editorial content, subscribers receive exclusive quarterly updates on plant and project spending statistics through our online version. It is important to understand that unlike other outlooks or forecasts that offer statistical information, our data is based on phone-verified project and plant information, conducted by our in-house staff of research specialists.

Get a jump on your competitors and enjoy an in-house advantage throughout the year by accessing the 2010 Pharmaceutical & Biotech Industry Outlook. Current users find the outlook a perfect companion to Industrial Info's Pharmaceutical Tracker - Online Database, containing operational plant data, as well as sites under development. Individual active capital and maintenance spending reports spanning North America also are covered within the Pharmaceutical Tracker.

Gain instant access to the outlook today by subscribing online at Industrialinfo.com or contact our Member Center at 1-800-762-3361.

Industrial Info Resources (IIR) is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy related markets. For more than 26 years, Industrial Info has provided plant and project opportunity databases, market forecasts, high resolution maps, and daily industry news.